In air transport, two infection control challenges stand out: the confined cabin space and the way cabin ventilation recirculates air. The tight quarters make it hard to physically separate an infected patient and keep others at a safe distance. The air system’s recirculation and airflow patterns can distribute airborne particles, potentially spreading pathogens if proper barriers aren’t used. A practical mitigation is to ensure appropriate personal protective equipment for crew and patients and to apply isolation precautions to limit exposure. In addition, minimize aerosol-generating procedures during transport, since those procedures increase airborne particles and the chance of transmission. Together, these steps address the unique risks of infection spread in flight.

During ascent or descent, the middle ear must be able to equalize with the outside air pressure through the Eustachian tube. If the tube doesn’t open adequately, a pressure difference builds across the tympanic membrane, leading to ear pain, muffled hearing, and sometimes vertigo as the inner ear is affected by the rapid pressure change. Prevention focuses on keeping the Eustachian tube working and using pressure-equalization techniques: swallow, yawn, or chew gum to encourage opening, and perform a gentle Valsalva maneuver (pinch the nose and softly blow with the mouth closed) to equalize air pressure. If congestion or a cold is present, treat it or delay flying if possible to improve tube function; avoid flying with significant nasal obstruction or active infection. If you can’t equalize or the pain persists, pause descent and attempt to equalize, or seek medical advice. Other signs like nosebleeds, nasal discharge, coughing, sore throat, or facial numbness are not typical indicators of middle ear barotrauma during flight.

In this situation the priority is safety for everyone on board. After a CBRN incident, clearance to fly hinges on proper decontamination and medical evaluation, plus reassurance that there’s no residual contamination or delayed symptoms developing. A short waiting period is used to let any off-gassing settle and to catch any evolving symptoms in a controlled setting before air transport. This minimum interval is chosen to balance the need to evacuate promptly with the need to avoid introducing contaminated or at-risk individuals into the aircraft. Longer delays would unnecessarily impede evacuation, while going too soon could risk onboard contamination or medical deterioration. So, the recommended approach is to wait a minimum safe period after decontamination and clearance, before proceeding with flight.

When a patient with a lower respiratory infection is hypoxemic in flight, the immediate goal is to rapidly raise and maintain oxygen saturation by delivering a high, reliable concentration of inspired oxygen, keeping SpO2 in a safe range despite reduced cabin oxygen. High-concentration oxygen delivered via a mask provides the most substantial and controllable FiO2, which is crucial for reversing hypoxemia quickly in the aircraft’s lower-oxygen environment. Targeting SpO2 at least 92% gives a margin above the hypoxemic threshold while avoiding unnecessary oversaturation. This approach is typically preferred in an acute, hypoxemic respiratory illness because it maximizes oxygen delivery to the compromised lungs and helps ensure stable oxygenation during flight. Lower-flow nasal cannula, while comfortable, cannot reliably deliver enough FiO2 to guarantee SpO2 ≥ 92% in this scenario, especially at altitude. A non-rebreather mask can deliver high FiO2 but depends on a good seal and patient cooperation, and targeting a relatively low SpO2 (88%) would not adequately treat active hypoxemia. AVenturi mask offers precise FiO2 but usually doesn’t reach the highest concentrations as quickly or reliably as a high-concentration mask, and aiming for very high SpO2 (like 96%) can be unnecessary unless indicated and is less critical than ensuring at least 92% in this setting. So, the best choice is delivering high-concentration oxygen with the aim of maintaining SpO2 around 92% or higher. Continuous monitoring and titration are essential to keep the patient within that safe range.

The main idea here is that aviation medical standards are set and kept by the Army Aeromedical Activity. This organization oversees the entire flight medicine program, establishing the criteria aircrew must meet to fly, coordinating flight physicals and medical waivers, and ensuring ongoing medical readiness across units. In other words, it serves as the central authority that maintains uniform medical fitness standards for Army aircrew. Other groups have important roles but not the authority to maintain those standards. The US Army Combat Readiness Center focuses on safety and readiness more broadly, not the medical criteria themselves. The Aeromedical Research Laboratory conducts studies to improve aviation medicine, which informs standards but doesn’t maintain them. The Department of Army Aviation Medicine provides clinical and support functions, but the policy and standard-setting oversight rests with the Army Aeromedical Activity.